Top China ADR Portal

China ADR stock research


Warning: strtotime(): It is not safe to rely on the system's timezone settings. You are *required* to use the date.timezone setting or the date_default_timezone_set() function. In case you used any of those methods and you are still getting this warning, you most likely misspelled the timezone identifier. We selected the timezone 'UTC' for now, but please set date.timezone to select your timezone. in /home1/chinaves/public_html/libraries/joomla/utilities/date.php on line 56

Warning: date(): It is not safe to rely on the system's timezone settings. You are *required* to use the date.timezone setting or the date_default_timezone_set() function. In case you used any of those methods and you are still getting this warning, you most likely misspelled the timezone identifier. We selected the timezone 'UTC' for now, but please set date.timezone to select your timezone. in /home1/chinaves/public_html/libraries/joomla/utilities/date.php on line 198

ADR REPORT: ADRs rebound, tracking gains on Wall Street

E-mail Print PDF



NEW YORK (MarketWatch) -- U.S.-listed shares of overseas companies rose on Tuesday, tracking overnight gains on Asian and European markets as well as a rebound on Wall Street.
The Bank of New York Composite ADR index was last up 2.4% at 162.94 points.
The Bank of New York Latin America ADR Index rose 4% to 268 points, the Asian ADR index added 2.9% at 156.37 points, and the Europe ADR index gained 2% to 162.97 points.
In New York, U.S. stocks rose sharply on Tuesday, lifting the Dow Jones Industrial Average by over 100 points, as investors extended a recovery in Asian markets and the dollar overnight. See Market Snapshot.
Shares of Swiss drug-maker Novartis rose 5.7% at $56.76, after the company said it won U.S. Food and Drug Administration clearance for Tekturna, a high-blood-pressure treatment. See full story.
Novartis has recently been hit by delays in securing clearances for some of its key drugs.
Shares of Israeli drug-maker Teva Pharmaceutical Industries (TEVA : Quote, Profile, Research)
rose 4% at $36.16. The generic drug-maker said Tuesday that it plans to sell its generic version of Purdue Frederick Co.'s OxyContin at least through the end of 2007. China Life(601628.SS: Quote, Profile , Research) (LFC: Quote, Profile , Research) (2628.HK: Quote, Profile , Research)
gained 7% at $39.27. Yanzhou Coal (1171.HK: Quote, Profile , Research) (YZC: Quote, Profile , Research)
rose 7.5% at $44.59.

Continued...


If you like us, spread the word to the fellow investors on your favorite Social Bookmarking websites
Reddit! Del.icio.us! Mixx! Free and Open Source Software News Google! Live! Facebook! StumbleUpon! TwitThis Joomla Free PHP